Enssle, Julius C.
Campe, Julia http://orcid.org/0000-0002-9290-9697
Moter, Alina
Voit, Isabel
Gessner, Alec
Yu, Weijia
Wolf, Sebastian
Steffen, Björn
Serve, Hubert
Bremm, Melanie
Huenecke, Sabine
Lohoff, Michael
Vehreschild, Maria
Rabenau, Holger F.
Widera, Marek http://orcid.org/0000-0001-5417-9307
Ciesek, Sandra
Oellerich, Thomas http://orcid.org/0000-0001-6570-6125
Imkeller, Katharina
Rieger, Michael A. http://orcid.org/0000-0002-4158-5872
von Metzler, Ivana
Ullrich, Evelyn http://orcid.org/0000-0001-8530-1192
Funding for this research was provided by:
Goethe-Universität Frankfurt am Main (Corona Funds, Corona Fonds, Corona Fonds, Corona Fonds, Corona Fonds)
Deutsche Forschungsgemeinschaft (SFB /CRC/ IRTG 1292, SFB / CRC / IRTG 1292)
Hessisches Ministerium für Wissenschaft und Kunst (LOEWE Priority Program CoroPan)
Innovation Center TheraNova Cluster project ENABLE
Article History
Received: 19 July 2023
Revised: 5 October 2023
Accepted: 9 October 2023
First Online: 4 December 2023
Competing interests
: SC received honoraria for advising Pfizer/ BioNTech. IvM received honoraria for advising Pfizer, Sanofi, BMS, GSK, Amgen, Janssen, Takeda and AstraZeneca. EU received honoraria for advising Phialogics and BMS. MW has received speaker fees from AstraZeneca. All other authors declare no competing interests to the present study.